These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 22971207

  • 21. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T, Vaszar LT, Faul JL, Zhao G, Berry GJ, Shi L, Qiu D, Benson G, Pearl RG, Kao PN.
    Circulation; 2003 Sep 30; 108(13):1640-5. PubMed ID: 12963647
    [Abstract] [Full Text] [Related]

  • 22. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
    Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ.
    Am J Physiol Heart Circ Physiol; 2013 Nov 01; 305(9):H1288-96. PubMed ID: 23997103
    [Abstract] [Full Text] [Related]

  • 23. Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
    McMurtry MS, Bonnet S, Michelakis ED, Bonnet S, Haromy A, Archer SL.
    Am J Physiol Lung Cell Mol Physiol; 2007 Oct 01; 293(4):L933-40. PubMed ID: 17675370
    [Abstract] [Full Text] [Related]

  • 24. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P, Rakotoniaina Z, Goirand F, Rochette L, Dumas M, Lirussi F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep 01; 373(6):401-14. PubMed ID: 16896805
    [Abstract] [Full Text] [Related]

  • 25. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.
    Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, Kim SE, Lee YS, Lee SD.
    Am J Respir Crit Care Med; 2005 Oct 15; 172(8):987-93. PubMed ID: 16002570
    [Abstract] [Full Text] [Related]

  • 26. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD, Wang Y, Zhang XH, Liu JR, Wang HL.
    Can J Physiol Pharmacol; 2012 Apr 15; 90(4):445-54. PubMed ID: 22448962
    [Abstract] [Full Text] [Related]

  • 27. Combination therapy improves vascular volume in female rats with pulmonary hypertension.
    Lachant DJ, Meoli DF, Haight D, Staicu S, Akers S, Glickman S, Ambrosini R, Champion HC, White RJ.
    Am J Physiol Lung Cell Mol Physiol; 2019 Oct 01; 317(4):L445-L455. PubMed ID: 31322432
    [Abstract] [Full Text] [Related]

  • 28. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul 01; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Simvastatin and sildenafil combine to attenuate pulmonary hypertension.
    Zhao L, Sebkhi A, Ali O, Wojciak-Stothard B, Mamanova L, Yang Q, Wharton J, Wilkins MR.
    Eur Respir J; 2009 Oct 01; 34(4):948-57. PubMed ID: 19797670
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
    Kato T, Nasu T, Sonoda H, Ito KM, Ikeda M, Ito K.
    J Cardiovasc Pharmacol; 2008 Jan 01; 51(1):18-23. PubMed ID: 18209564
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of combined therapy with a Rho-kinase inhibitor and prostacyclin on monocrotaline-induced pulmonary hypertension in rats.
    Tawara S, Fukumoto Y, Shimokawa H.
    J Cardiovasc Pharmacol; 2007 Aug 01; 50(2):195-200. PubMed ID: 17703136
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.